Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease

Clinics in Liver Disease

Volumn 20, Issue 4, 2016, Pages 607-628

  Nelson, Noele P ^a   Easterbrook, Philippa J ^b   McMahon, Brian J ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c ALASKA NATIVE MEDICAL CENTER   (United States)

Author keywords

Birth dose; Hepatitis B vaccine; Hepatitis B virus; Perinatal transmission; Vaccine impact

Indexed keywords

ANTIVIRUS AGENT; DNA; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HEPATITIS B ANTIGEN;

ALASKA; DISEASE TRANSMISSION; ECONOMIC EVALUATION; EPIDEMIC; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HIGH RISK PREGNANCY; HUMAN; INCIDENCE; INFECTION RATE; LIVER CANCER; LIVER CELL CARCINOMA; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; NONHUMAN; PREVENTIVE HEALTH SERVICE; RESOURCE ALLOCATION; REVIEW; RISK REDUCTION; UNITED STATES; WORLD HEALTH ORGANIZATION; GLOBAL HEALTH; IMMUNOLOGY; PROCEDURES; VACCINATION; VIROLOGY;

GLOBAL HEALTH; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INCIDENCE; VACCINATION;

EID: 84992187280     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2016.06.006     Document Type: Review

References (78)

1. 1 World Health Organization. Hepatitis B. Available at: www.who.int/topics/hepatitis/factsheets/en. Accessed June 22, 2016.
2. 2 WHO position paper on hepatitis B vaccines - October 2009. Wkly Epidemiol Rec 84 (2009), 405–420.
3. 3 Schweitzer, A., Horn, J., Mikolajczyk, R.T., et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386:10003 (2015), 1546–1555.
4. 4 GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:9963 (2015), 117–171.
5. 5 Franco, E., Bagnato, B., Marino, M.G., et al. Hepatitis B: epidemiology and prevention in developing countries. World J Hepatol 4 (2012), 74–80.
6. 6 Wasley, A., Kruszon-Moran, D., Kuhnert, W., et al. The prevalence of hepatitis B infection in the United States in the era of vaccination. J Infect Dis 202 (2010), 192–201.
7. 7 Cohen, C., Evans, A.A., London, W.T., et al. Underestimation of chronic hepatitis B infection in the United States of America. J Viral Hepat 15 (2008), 12–13.
8. 8 National Academies of Sciences, Engineering, and Medicine, Eliminating the public health problem of hepatitis B and C in the United States: Phase one report. 2016, The National Academies Press, Washington, DC.
9. 9 Roberts, H., Kruszon-Moran, D., Ly, K.N., et al. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012. Hepatology 63:2 (2016), 388–397.
10. 10 Mitchell, T., Armstrong, G.L., Hu, D.J., et al. The increasing burden of imported chronic hepatitis B—United States, 1974-2008. PLoS One, 6, 2011, e27717.
11. 11 Institute of Medicine (US) Committee on the Prevention and Control of Viral Hepatitis Infections, Grossblatt, N., (eds.) Hepatitis and liver cancer: national strategy for prevention and control of hepatitis B and C, 2010, National Academies Press, Washington, DC.
12. 12 Weinbaum, C.M., Williams, I., Mast, E.E., et al., Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 57 (2008), 1–20.
13. 13 Kowdley, K.V., Wang, C., Welch, S., et al. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology 56 (2012), 422–433.
14. 14 Available at: http://www.cdc.gov/nchs/nhanes/about_nhanes.htm. Accessed August 15, 2016.
15. 15 Centers for Disease Control and Prevention. Asian Americans and hepatitis B. 2013. Available at: http://www.cdc.gov/features/aapihepatitisb/. Accessed May 1, 2015.
16. 16 CDC, Surveillance for viral hepatitis—United States, 2014. 2014, US Department of Health and Human Services, CDC, Atlanta, GA Available at: http://www.cdc.gov/hepatitis/statistics/2014surveillance/index.htm.
17. 17 Harris, A.M., Iqbal, K., Schillie, S., et al. Increases in acute hepatitis B virus infections - Kentucky, Tennessee, and West Virginia, 2006-2013. MMWR Morb Mortal Wkly Rep 65:3 (2016), 47–50.
18. 18 Centers for Disease Control and Prevention, Update: recommendations to prevent hepatitis B virus transmission-United States. MMWR Morb Mortal Wkly Rep 44 (1995), 574–575.
19. 19 Edmunds, W.J., Medley, G.F., Nokes, D.J., et al. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci 253 (1993), 197–201.
20. 20 Hyams, K.C., Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 20 (1995), 992–1000.
21. 21 Available at: http://www.cdc.gov/hepatitis/Resources/Professionals/PDFs/ABCTable.pdf. Accessed August 15, 2016.
22. 22 Beasley, R.P., Trepo, C., Stevens, C.E., et al. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 105 (1977), 94–98.
23. 23 McMahon, B.J., Two key components to address chronic hepatitis B in children: detection and prevention. J Pediatr 167 (2015), 1186–1187.
24. 24 Marinier, E., Barrois, V., Larouze, B., et al. Lack of perinatal transmission of hepatitis B virus infection in Senegal, West Africa. J Pediatr 106 (1985), 843–849.
25. 25 Beasley, R.P., Hwang, L.Y., Lee, G.C., et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2 (1983), 1099–1102.
26. 26 McMahon, B.J., Alward, W.L., Hall, D.B., et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151 (1985), 599–603.
27. 27 Beasley, R.P., Hwang, L.Y., Lin, C.C., et al. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 146 (1982), 198–204.
28. 28 Coursaget, P., Yvonnet, B., Chotard, J., et al. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol 22 (1987), 1–5.
29. 29 Petersen, N.J., Barrett, D.H., Bond, W.W., et al. Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appl Environ Microbiol 32 (1976), 572–574.
30. 30 Bond, W.W., Favero, M.S., Petersen, N.J., et al. Survival of hepatitis B virus after drying and storage for one week. Lancet 1 (1981), 550–551.
31. 31 Centers for Disease Control and Prevention, Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR Recomm Rep 40:RR-8 (1991), 1–9.
32. 32 Available at: http://www.cdc.gov/hepatitis/outbreaks/pdfs/healthcareinvestigationtable.pdf. Accessed August 15, 2016.
33. 33 Hepatitis B control through immunization: a reference guide. Available at: http://www.who.int/immunization/sage/meetings/2015/october/8_WPRO_Hepatitis_B_Prevention_Through_Immunization_Regional_Reference_Guide.pdf. Accessed August 15, 2016.
34. 34 Introduction of hepatitis B vaccine into childhood immunization services. Management guidelines, including information for health workers and parents. Available at: http://www.wpro.who.int/hepatitis/whovb0131.pdf. Accessed May 13, 2016.
35. 35 Goldstein, S.T., Zhou, F.J., Hadler, S.C., et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34 (2005), 1329–1339.
36. 36 WHO global plan of action on workers’ health (2008-2017): baseline for implementation. Available at: http://www.who.int/occupational_health/who_workers_health_web.pdf. Accessed August 15, 2016.
37. 37 Forde, K.A., Tanapanpanit, O., Reddy, K.R., Hepatitis B and C in African Americans: current status and continued challenges. Clin Gastroenterol Hepatol 12:5 (2014), 738–748.
38. 38 Mast, E.E., Margolis, H.S., Fiore, A.E., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 54 (2005), 1–31.
39. 39 Schillie, S., Murphy, T.V., Fenlon, N., et al. Update: shortened interval for postvaccination serologic testing of infants born to hepatitis B-infected mothers. MMWR Morb Mortal Wkly Rep 64:39 (2015), 1118–1120.
40. 40 Available at: http://www.cdc.gov/vaccines/schedules/index.html. Accessed August 15, 2016.
41. 41 Mast, E.E., Weinbaum, C.M., Fiore, A.E., et al., Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 55:RR-16 (2006), 1–33 [quiz: CE1–4; Erratum appears in MMWR Morb Mortal Wkly Rep 2007;56(42):1114].
42. 42 Schreeder, M.T., Bender, T.R., McMahon, B.J., et al. Prevalence of hepatitis B in selected Alaskan Eskimo villages. Am J Epidemiol 118 (1983), 543–549.
43. 43 Lanier, A.P., McMahon, B.J., Alberts, S.R., et al. Primary liver cancer in Alaskan natives. 1980-1985. Cancer 60 (1987), 1915–1920.
44. 44 Livingston, S.E., Simonetti, J.P., Bulkow, L.R., et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology 133 (2007), 1452–1457.
45. 45 Heyward, W.L., Bender, T.R., McMahon, B.J., et al. The control of hepatitis B virus infection with vaccine in Yupik Eskimos. Demonstration of safety, immunogenicity, and efficacy under field conditions. Am J Epidemiol 121 (1985), 914–923.
46. 46 McMahon, B.J., Rhoades, E.R., Heyward, W.L., et al. A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives. Lancet 2 (1987), 1134–1136.
47. 47 McMahon, B.J., Schoenberg, S., Bulkow, L., et al. Seroprevalence of hepatitis B viral markers in 52,000 Alaska natives. Am J Epidemiol 138 (1993), 544–549.
48. 48 Peng, C.Y., Chien, R.N., Liaw, Y.F., Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy. J Hepatol 57:2 (2012 Aug), 442–450.
49. 49 Expanded Programme on Immunization (EPI) of the Department of Immunization, Vaccines and Biologicals. Practices to improve coverage of the hepatitis B birth dose vaccine, 2012, World Health Organization, Geneva (Switzerland) WHO/IVB/12.11. Available at: http://www.who.int/immunization/documents/control/who_ivb_12.11/en/ Accessed May 13, 2016.
50. 50 WHO/UNICEF coverage estimates 2014 revision. 2015. Available at: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragebcg.html. Accessed August 15, 2016.
51. 51 Centers for Disease Control and Prevention (CDC), Global routine vaccination coverage–2012. MMWR Morb Mortal Wkly Rep 62:43 (2013), 858–861.
52. 52 Adams, D., Fullerton, K., Jajosky, R., et al. Summary of notifiable infectious diseases and conditions - United States, 2013. MMWR Morb Mortal Wkly Rep 62:53 (2015), 1–122.
53. 53 Hill, H.A., Elam-Evans, L.D., Yankey, D., et al. National, state, and selected local area vaccination coverage among children aged 19-35 months - United States, 2014. MMWR Morb Mortal Wkly Rep 64:33 (2015), 889–896.
54. 54 Reagan-Steiner, S., Yankey, D., Jeyarajah, J., et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years–United States, 2014. MMWR Morb Mortal Wkly Rep 64:29 (2015), 784–792.
55. 55 Williams, W.W., Lu, P.J., O'Halloran, A., et al. Surveillance of vaccination coverage among adult populations - United States, 2014. MMWR Surveill Summ 65:1 (2016), 1–36.
56. 56 Alter, M.J., Hadler, S.C., Margolis, H.S., et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 263 (1990), 1218–1222.
57. 57 Centers for Disease Control and Prevention, Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 60:RR-7 (2011), 1–45.
58. 58 Schillie, S., Murphy, T.V., Sawyer, M., et al. CDC guidance for evaluating healthcare personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep 62:RR-10 (2013), 1–19.
59. 59 Chien, Y.-C., Jan, C.-F., Kuo, H.-S., et al. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 28 (2006), 126–135.
60. 60 Stroffolini, T., Mele, A., Tosti, M.E., et al. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol 33 (2000), 980–985.
61. 61 Cancer facts and figures. 2016. Available at: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf. Accessed August 15, 2016.
62. 62 El-Serag, H.B., Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142 (2012), 1264–1273.e1.
63. 63 McMahon, B.J., Bulkow, L.R., Singleton, R.J., et al. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 54 (2011), 801–807.
64. 64 Wichajarn, K., Kosalaraksa, P., Wiangnon, S., Incidence of hepatocellular carcinoma in children in Khon Kaen before and after National Hepatitis B Vaccine Program. Asian Pac J Cancer Prev 9 (2008), 507–509.
65. 65 Chang, M.H., Chen, C.J., Lai, M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336 (1997), 1855–1859.
66. 66 Terrault, N.A., Bzowej, N.H., Chang, K.M., et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 63 (2016), 261–283.
67. 67 World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. 2015. Available at: http://www.who.int/hiv/pub/hepatitis/hepatitis-b-guidelines/en/. Accessed August 15, 2016.
68. 68 Liang, T.J., Block, T.M., McMahon, B.J., et al. Present and future therapies of hepatitis B: from discovery to cure. Hepatology 62 (2015), 1893–1908.
69. 69 Bridges, C.B., Hurley, L.P., Williams, W.W., et al. Meeting the challenges of immunizing adults. Am J Prev Med 49 (2015), S455–S464.
70. 70 Sutanto, A., Suarnawa, I.M., Nelson, C.M., et al. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device. Bull World Health Organ 77:2 (1999), 119–126.
71. 71 Chen, H.L., Lin, L.H., Hu, F.C., et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 142 (2012), 773–781.e2.
72. 72 Brown, R.S. Jr., McMahon, B.J., Lok, A.S., et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis. Hepatology 63 (2016), 319–333.
73. 73 Terrault NA, Bzowej NH, Chang K, et al. AASLD Guidelines for Treatment of chronic Hepatitis B. Hepatology 2015. Availabe at: https://www.aasld.org/sites/default/files/guideline_documents/hep28156.pdf. Accessed September 7, 2016.
74. 74 Bruce, M.G., Bruden, D., Hurlburt, D., et al. Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis 214:1 (2016), 16–22.
75. 75 Liang, X., Bi, S., Yang, W., et al. Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:47 (2009), 6550–6557.
76. 76 Hadler, S.C., Fuqiang, C., Averhoff, F., et al. The impact of hepatitis B vaccine in China and in the China GAVI Project. Vaccine 31:Suppl 9 (2013), J66–J72.
77. 77 Kolwaite, A.R., Xeuatvongsa, A., Ramirez-Gonzalez, A., et al. Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR. Vaccine 34:28 (2016), 3324–3330.
78. 78 Van Damme, P., Ward, J., Shouval, D., et al. Hepatitis B vaccines. Plotkin, S., Orenstein, W., Offit, P., (eds.) Vaccines, 2012, Saunders, (China), 183–204.